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The bone marrow (BM) microenvironment is com-
posed of multiple niche cells that, by producing
paracrine factors, maintain and regenerate the
hematopoietic stem cell (HSC) pool (Morrison and
Spradling, 2008). We have previously demonstrated
that endothelial cells support the proper regeneration
of the hematopoietic system followingmyeloablation
(Butler et al., 2010; Hooper et al., 2009; Kobayashi
et al., 2010). Here, we demonstrate that expression
of the angiocrine factor Jagged-1, supplied by the
BMvascular niche, regulates homeostatic and regen-
erative hematopoiesis through a Notch-dependent
mechanism. Conditional deletion of Jagged-1 in
endothelial cells (Jag1(ECKO) mice) results in a pro-
found decrease in hematopoiesis and premature
exhaustion of the adult HSC pool, whereas quantifi-
cation and functional assays demonstrate that loss
of Jagged-1 does not perturb vascular or mesen-
chymal compartments. Taken together, these data
demonstrate that the instructive function of endo-
thelial-specific Jagged-1 is required to support the
self-renewal and regenerative capacity of HSCs in
the adult BM vascular niche.
INTRODUCTION
The bone marrow (BM) microenvironment is a complex system
comprising specialized niche cells that regulate themaintenance
of the hematopoietic stem cell (HSC) pool through the produc-
tion of prohematopoietic factors (Morrison and Spradling,
2008). Crosstalk among various niche cells maintains and regen-
erates HSCs. However, the precise mechanism by which niche1022 Cell Reports 4, 1022–1034, September 12, 2013 ª2013 The Aucells communicate with the HSCs and their progeny to reconsti-
tute hematopoiesis is unknown. Osteoblasts have been shown
to sustain the quiescence of HSCs by elaboration of specific
growth factors (Adams et al., 2006; Lo Celso et al., 2009; Xie
et al., 2009; Yoshihara et al., 2007). It has been strongly impli-
cated that the BM vascular niche, which consists of a vast
network of thin-walled, fenestrated sinusoidal endothelial cells
and perivascular stromal cells, can provide the proper milieu of
prohematopoietic factors that are needed to support the HSC
pool (Butler et al., 2010; Ding and Morrison, 2013; Ding et al.,
2012; Himburg et al., 2010; Hooper et al., 2009; Kobayashi
et al., 2010; Me´ndez-Ferrer et al., 2010; Sugiyama et al., 2006;
Yamazaki et al., 2011).
Our group has previously demonstrated that Akt-activated
endothelial cells are indispensable for the regeneration of the
Notch-dependent HSC pool following hematopoietic insult (But-
ler et al., 2010). Here, we demonstrate that conditional deletion of
Jagged-1 in endothelial cells (Jag1(ECKO)) results in a decrease in
phenotypic and functional long-term (LT)-HSCs at steady state,
aswell as a significant decrease in Notch signaling in hematopoi-
etic stem and progenitor cells (HSPCs). Furthermore, Jag1(ECKO)
mice have a profound deficiency in hematopoietic recovery
following sublethal irradiation leading to the ultimate demise of
half of the mice. Cell-cycle analysis of LT-HSCs from Jag1(ECKO)
mice revealed that a significant portion of the HSC pool was
actively cycling. Serial administration of low-dose chemothera-
peutic agents and secondary and tertiary transplantation assays
results in the premature exhaustion of the LT-HSC in Jag1(ECKO)
mice, confirming that endothelial-specific expression of Jagged-
1maintains the quiescence and self-renewal of LT-HSCs. There-
fore, expression of Jagged-1 by the vascular niche supports
functional hematopoiesis by preventing premature exhaustion
of the HSC pool. Modulating the angiocrine repertoire of endo-
thelium could lead to the discovery of as-yet-unrecognized
instructive factors that augment the use of HSCs for the treat-
ment of hematological disorders.thors
RESULTS
Maintenance of the HSC Pool Requires
Endothelial-Specific Expression of Jagged-1
Previous reports have demonstrated that using the conditional
Mx1 cre transgene to delete Jagged-1 in the cellular compart-
ments within the BM microenvironment did not result in
phenotypic or functional defects in the hematopoietic system
(Mancini et al., 2005). In order to determine the most efficient
in vivo model system to delete Jagged-1 specifically in endo-
thelial cells, we generated two endothelial cell-specific cre
transgenic models. We utilized the constitutive VE-cadherin
cre and the inducible VE-cadherin creERT2 and compared
these systems to the previously described inducible Mx1 cre
system (Figures 1A, 1B, and S1). Isolation of BM endothelial
cells demonstrated that both the constitutive VE-cadherin
cre and the inducible VE-cadherin creERT2 were efficient at
deleting floxed Jag1 exons 4–5. However, only the constitu-
tive VE-cadherin cre resulted in complete excision of exons
4–5 in the Jag1 gene. Notably, the inducible Mx1 cre system
did not delete Jagged-1 in BM endothelial cells, with tran-
script levels similar to controls (Figures 1A and S1). Analysis
of peripheral blood confirmed that induction of Mx1 cre with
Poly(I:C) resulted in complete excision of Jag1 exons 4–5,
whereas both VE-cadherin cre systems did not affect Jag1
transcript in hematopoietic cells (Figures 1B and S1) as
compared to controls. Therefore, these data suggest that
the previous report demonstrating that expression of
Jagged-1 in the BM microenvironment did not regulate hema-
topoiesis could be due to the inefficient deletion of endothe-
lial-specific Jagged-1.
Because constitutive VE-cadherin cre resulted in complete
deletion of exons 4–5 of Jag1 in BM endothelial cells
(Jag1(ECKO) mice), we analyzed 8- to 12-week-old Jag1(ECKO)
mice, and they did not exhibit any defects in BM cellularity or
the ratios of Lin+ hematopoietic cells (Figures 1C and 1E).
However, endothelial-specific deletion of Jagged-1 resulted
in a significant decrease in the number of phenotypic LT-
HSCs (Figure 1D). To confirm that the decrease in phenotypic
LT-HSCs resulted in a defect in stem cell function, we exam-
ined the long-term repopulation capacity of whole BM from
control and Jag1(ECKO) mice in BM transplantation assays.
We quantified the engraftment potential of whole BM cells
from control and Jag1(ECKO) mice by performing a competi-
tive repopulation assay, in which 5 3 105 hematopoietic cells
from CD45.2 Jag1fl/fl control and Jag1(ECKO) mice were
competed with 5 3 105 hematopoietic cells from CD45.1
mice. These experiments revealed a significant decrease in
the engraftment potential of hematopoietic cells isolated
from Jag1(ECKO) mice (Figures 1F and 1G). Additionally, we
performed limiting dilution transplantation studies and
assessed the long-term, multilineage reconstitution ability of
whole BM cells from control and Jag1(ECKO) mice to deter-
mine the frequency of functional HSCs. We found that there
was a 3-fold decrease in the frequency of long-term, multili-
neage repopulating cells in Jag1(ECKO) mice (1/130,629 con-
trol (Jag1fl/fl control) versus 1/396,112 Jag1(ECKO), respectively)
(Figure 1H).Cell ReEndothelial-Specific Deletion of Jagged-1 Interferes
with Notch Signaling in HSPCs
To date, the in vivo regulation of HSC self-renewal and differenti-
ationbyNotch signaling has not been fully determined. The useof
a wide array of genetic tools has suggested that Notch signaling
is dispensable for the maintenance of the hematopoietic system
under steady-state conditions (Maillard et al., 2008). However,
this study did not fully demonstrate whether there was a signifi-
cant decrease in Notch downstream target genes following
genetic inhibition of canonical Notch signaling in the HSPCs.
Nonetheless, studies have demonstrated that a Jagged-1-Notch
2 receptor interaction is efficient to maintain primitive HSPCs
(Varnum-Finney et al., 1998) and that Notch 2 dictates the rate
of hematopoietic recovery following myeloablative stress (Var-
num-Finney et al., 2011), suggesting a role for Notch signaling
in homeostatic and regenerative hematopoiesis.
To determine if endothelial-specific deletion of Jagged-1
results in a significant decrease of Notch signaling in HSPCs
(cKit+LineageSca-1+, KLS), we first analyzed the expression
levels of Notch receptors on HSPCs in Jag1fl/fl control and
Jag1(ECKO) mice (Figure 2A). Our data confirm that the primary
Notch receptor expressed on HSPCs is Notch 2 (Oh et al.,
2013). We next analyzed the expression of downstream Notch
target genes and found that there was a significant decrease in
Hes1 and Hey1 expression in Jag1(ECKO) HSPCs as compared
to Jag1fl/fl control HSPCs (Figure 2B). To formally quantify the
decrease in the primary Notch downstream target Hes1 in
Jag1(ECKO) HSPCs, we utilized a Hes1-GFP knockin mouse
model (Fre et al., 2011) and transplanted 53 105 whole BM cells
from Hes1-GFP mice into Jag1fl/fl control and Jag1(ECKO) mice
and allowed for the hematopoietic system to fully recover for
4 months (Figure 2C). At 4 months posttransplant, we analyzed
the percentage of GFP+ whole BM cells circulating in the periph-
eral blood and found that there was a 2-fold decrease in GFP
expression (Figure 2D). Additionally, we analyzed the number
of KLS cells per 106 hematopoietic cells and found that there
was a profound decrease in the frequency of KLS cells in
Jag1(ECKO)mice, as well as a significant decrease in the percent-
age of GFP+ cells in the KLS fraction of Jag1(ECKO) mice as
compared to Jag1fl/fl controls (Figures 2E and 2F). Therefore,
endothelial-specific deletion of Jagged-1 can directly lead to
defects in HSPCs in a Notch-dependent manner.
Endothelial-Specific Deletion of Jagged-1 Impairs
Ex Vivo Expansion of Notch+ KLS Cells
To formally test if expression of Jagged-1 supplied specifically by
the endothelial cells is required for the expansion and mainte-
nance of the hematopoietic system, we isolated endothelial
cells from Jag1fl/fl control and Jag1(ECKO) mice (Figures 3A–3C).
Utilizing an endothelial cell/HSC coculture system previously
described in our laboratory (Butler et al., 2010; Kobayashi et al.,
2010), we isolated KLS cells fromNotch.GFP reporter mice (Dun-
can et al., 2005) and cocultured them with endothelial cells
isolated from Jag1fl/flcontrol or Jag1(ECKO)mice in serum-free cul-
ture conditions supplemented with 50 ng/ml of murine stem cell
factor for 7 days. Notch.GFP reporter mice are transgenic mice
that were generated using an EGFP cassette that was placed
under the control of the CBF1/RBPJ promoter. Cells that engageports 4, 1022–1034, September 12, 2013 ª2013 The Authors 1023
Figure 1. Maintenance of the HSC Pool Requires Endothelial-Specific Expression of Jagged-1
Constitutive VE-cadherin cre transgenic mice promote efficient in vivo deletion of an exon 4–5 floxed Jag1 allele in BM endothelial cells. Jag 1fl/fl conditional mice
were crossed with either constitutive VE-cadherin cre, tamoxifen (Tmx)-inducible VE-cadherin creERT2, or Poly(I:C)-inducible Mx1 cre mice, and cDNA was
synthesized from either BM endothelial cells sorted to purity (CD45, Ter119, VE-Cadherin+, Isolectin GS-IB4+) or peripheral blood.
(A) RT-PCR using primers spanning conditional Jag1 exons 4–5 were used to assay for the extent of full-length (FL) and deleted (D) transcripts in BM ECs.
VE-cadherin expression was used to assess for purity.
(B) RT-PCR analysis of peripheral blood using Jag1-specific primers located within floxed exon 4 demonstrate efficient elimination of exon 4 containing
transcripts in Mx1 cre, but not constitutive VE-cadherin cre or inducible VE-cadherin creERT2 mice.
(C and D) Steady-state analysis of control and Jag1(ECKO) mice demonstrates similar levels in BM cellularity (C) but a significant increase in the frequency of
phenotypic LT-HSC per 106 whole BM cells (D) as compared to Jag1fl/fl controls (n = 12/cohort).
(E) Analysis of lineage-committed progenitors shows no significant differences in Jag1(ECKO) mice as compare to Jag1fl/fl controls (n = 8 control mice; n = 10
Jag1(ECKO) mice).
(F) To test if whole BM from Jag1(ECKO)mice had decreased engraftment potential, we performed a competitive repopulation assay and demonstrated that whole
BM from wild-type donors were significantly more efficient at sustaining long-term repopulating ability as compared to Jag1(ECKO) mice.
(legend continued on next page)
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Figure 2. Endothelial-Specific Deletion of Jagged-1 Interferes with Notch Signaling in HSPCs
(A) KLS HSPCs were sorted from control and Jag1(ECKO) mice and analyzed for Notch receptors.
(B) Downstream Notch target genes. There were no significant differences between (A) Notch receptors but significant decrease in the (B) Notch target genes
Hes1 and Hey1 in Jag1(ECKO) KLS cells (grey bars).
(C) Whole BM (5 3 105) from Hes1-GFP knockin mice was transplanted into lethally irradiated Jag1fl/fl control and Jag1(ECKO) mice and allowed to recover for
4 months.
(D) Percentage of GFP+ whole bone marrow.
(E) Total number of KLS cells.
(F) Percentage of GFP+ KLS cells. There was a significant decrease in whole BM and KLS cells positive for Hes1-GFP in Jag1(ECKO) mice.
See also Figure S2. All data represent ± SD (*p<0.05; **p<0.01).in Notch receptor/Notch ligand signaling initiate expression of
target genes, as well as expression of EGFP, which allows for
the accurate monitoring of Notch signaling in our coculture sys-
tem. Upon analysis, we found that total hematopoietic expansion
was dramatically higher in Jag1(ECKO) culture conditions (Fig-
ure 3D), but that total Lineage-negative expansion was similar in
bothJag1fl/flcontrol andJag1(ECKO)coculturesystems (Figure3F).
However, there was a significant decrease in the total number of
KLS.GFP+ hematopoietic cells when cocultured with Jag1(ECKO)
endothelial cells compared with a Jag1fl/fl control (Figure 3G).
Analysis of the Lineage+ fraction demonstrated that the majority
of the terminally differentiated cells were CD11b+/Gr-1+ myeloid
cells in both coculture conditions, with cocultures of KLS cells
with Jag1(ECKO) endothelial cells resulting in a significant increase
in myeloid cells as compared to Jag1fl/fl control endothelial cells
(Figure 3E). Upon transplantation of equal number of KLS cells
from each coculture condition, hematopoietic cells cocultured
with Jag1fl/fl control endothelial cells had a significant advantage(G) Representative contour plots of CD45.1 versus CD45.2 engraftment 4 month
(H) Limiting dilution analysis of the frequency of long-term, multilineage reconstit
three independent experiments). All data represent mean ± SD (*p < 0.05).
See also Figures S1 and S3.
Cell Rein their engraftment potential and similar levels of donor-derived
multilineage engraftment when compared to hematopoietic cells
cocultured with Jag1(ECKO) endothelial cells (Figures 3H and 3I).
Endothelial-Specific Deletion of Jagged-1 Inhibits
Hematopoietic Regeneration
To address the contribution of endothelial-specific expression
of Jagged-1 to reconstitution of hematopoiesis, we utilized the
aforementioned Jag1(ECKO) mice. To this end, Jag1fl/fl control
and Jag1(ECKO) mice were subjected to 650 Rads of sublethal
irradiation and recovery of white blood cells and survival of
the cohorts were monitored (Figures 4A and 4B). The difference
in survival was significant between the two cohorts, with 50% of
the Jag1(ECKO) mice failing to thrive by day 18 after sublethal
radiation (Figure 4B). Analysis of Jagged-1 expression in BM
endothelial cells at steady state and day 10 after sublethal radi-
ation demonstrated a nonsignificant increase in Jagged-1
expression following the myelosuppressive insult (Figure 4C).s posttransplant (n = 5/cohort, three independent experiments).
ution cells in Jag1(ECKO) mice as compared to Jag1fl/fl controls (n = 20/cohort,
ports 4, 1022–1034, September 12, 2013 ª2013 The Authors 1025
Figure 3. Endothelial-Specific Deletion of Jagged-1 Impairs Ex Vivo Expansion of Notch+ KLS Cells
(A–C) Confirmation of endothelial cell phenotype of isolated endothelium from Jag1fl/fl control and Jag1(ECKO) mice. (A) Flow cytometric analysis of cultured
endothelial cells based on the coexpression of endothelial-specific markers CD31 and VE-cadherin. (B) Fluorescent images demonstrating junctional
VE-cadherin staining of cultured endothelial cells. (C) RT-PCR confirmation of Jagged-1 deletion in cultured Jag1(ECKO) endothelium.
(D–G) 50,000 Lineage hematopoietic cells from Notch.GFP reporter mice were cocultured with control and Jag1(ECKO) endothelial cells for 7 days in serum-free
culture conditions supplemented with 50 ng/ml of stem cell factor. Hematopoietic cells cocultured with Jag1(ECKO) endothelial cells resulted in a significant
increase in expansion of the total number of hematopoietic cells (D) with the majority of the cells being CD11b+Gr1+ Lineage cells (E) but with no change in the
expansion of Lineage cells (F) when compared to control endothelial cells. However, there was a significant decrease in the total number of KLS cells (data not
shown) and KLS cells that were actively signaling through the Notch pathway (GFP+) (G).
(H and I) Competitive repopulation of expanded hematopoietic cells demonstrates that Lineage hematopoietic cells that were coculturedwith control endothelial
cells resulted in the expansion of HSCs with a greater (H) engraftment potential with similar (I) multilineage potential as compared to Jag1(ECKO) endothelial cells.
All data represent mean ± SD (**p < 0.01, ***p < 0.001); scale bar 50 mm.Because the Jag1(ECKO) mice began dying at day 10 postirradi-
ation, we quantified the total number of hematopoietic and KLS
cells at day 10 postirradiation, which exhibited a significant
decrease in total and KLS hematopoietic cell number (Figures
4D and 4E) in the Jag1(ECKO) mice when compared with
Jag1fl/fl controls. Upon examination of the diaphysis and trabec-
ular regions of the BM cavity on day 10 postirradiation, we1026 Cell Reports 4, 1022–1034, September 12, 2013 ª2013 The Aufound that the structural integrity of the BM vascular network
was largely intact and most of the hematopoietic cells were
found as tightly associated cellular packs within the BM paren-
chyma in Jag1fl/fl control mice as compared to Jag1(ECKO) mice
(Figure 4F). However, it is important to note that there were no
differences in the total number of perfusable BM endothelial
cells (Figure 4F).thors
Figure 4. Endothelial-Specific Deletion of Jagged-1 Interferes with Hematopoietic Regeneration
(A) Analysis of white blood cell recovery in Jag1(ECKO) mice following sublethal irradiation of 650 Rads (n = 10/cohort up to day 10, n = 6 for duration of analysis,
three independent experiments).
(B) Survival curve of Jag1fl/fl control and Jag1(ECKO) mice after sublethal irradiation. All of the control mice fully recover and survived. However, Jag1(ECKO) mice
begin succumbing to hematopoietic failure by day 10, and 50% of the cohort has died by day 18 after sublethal irradiation.
(C) Jagged-1 expression in BM endothelial cells at steady state and day 10 after sublethal irradiation.
(D and E) Analysis of the BM at day 10 after sublethal irradiation demonstrated that Jag1(ECKO) mice have a significant decrease in BM cellularity (D) and a
decrease in KLS HSPCs (E) as compared to Jag1fl/fl controls (n = 4/cohort, three independent experiments).
(F) Representative fluorescent images of the diaphysis and trabecular regions of Jag1fl/fl and Jag1(ECKO)mice aswell as quantification of functional BM endothelial
cells. Note the increase in BM cellular integrity in Jag1fl/fl control mice as compared to Jag1(ECKO)mice without any significant changes in vascular density within
the BM. All data represent mean ± SD (*p < 0.05, **p < 0.01); scale bar 50 mm.Endothelial-Specific Deletion of Jagged-1 Does Not
Result in Postnatal Vascular Deficiencies
It is plausible that the hematopoietic failure demonstrated in
Jag1(ECKO) mice was due to a decrease in the passive function
of endothelial cells to deliver the proper nutrients and oxygen
necessary to promote efficient regeneration of the hematopoiet-
ic system. Indeed, Jagged-1 has been demonstrated to play a
major role in vascular integrity during embryonic organogenesis.
Global knockout of Jagged-1 leads to embryonic lethality due to
vascular abnormalities, including vascular dropout in the vast
endothelial network of the yolk sac and forebrain (High et al.,
2008; Robert-Moreno et al., 2008; Xue et al., 1999), as well as
disrupted vascular smooth muscle cell differentiation. Further-
more, in Jag1(ECKO)mice that were generated using the inducible
Pdgfb-iCreERT2 system, one could detect a decreased vascular
density in the developing postnatal retina with decreased arterial
vascular smooth muscle coverage (Benedito et al., 2009). Utiliz-
ing our constitutive VE-cadherin cre system, we analyzed
postnatal (P6) retinal development and found that there was noCell Resignificant decrease in the vascular density of Jag1(ECKO) mice
when compared to Jag1fl/fl control retinas (Figures 5A and 5B).
To assess the integrity of the BM vascular niche during homeo-
static hematopoiesis, Jag1fl/fl control and Jag1(ECKO) mice were
intravitally injected via the retro orbital sinus with low doses of
an Alexa-Fluor-647-conjugated VE-cadherin antibody (10 mg/
mouse) 10 min before sacrifice to visualize the number and
morphology of perfused vessels and to analyze the architecture
of the hematopoietic compartment (Figure 5C). Subsequently,
flow cytometry was used to quantify the number of patent and
functional CD45Ter119VEcadherin+ BM endothelial cells (Fig-
ure 5D). Using this approach, we demonstrated that the total
number of functionally perfusable VE-cadherin+ BM endothelial
cells that retained their anastomosis to circulation was similar
in Jag1(ECKO) and Jag1fl/fl control mice (Figure 5D). Furthermore,
we tested whether Jagged-1 modulated the angiocrine profile of
BM endothelial cells by disrupting functional capacity of BM
endothelial cells to serve as niche cells. To this end, we isolated
BM endothelial cells from Jag1fl/fl control and Jag1(ECKO) miceports 4, 1022–1034, September 12, 2013 ª2013 The Authors 1027
Figure 5. Jag1(ECKO) Mice Do Not Manifest Postnatal Vascular Deficiencies that Lead to Hematopoietic Dysfunction
(A) Visualization of the retinal vasculature at P6 using Isolectin GS-IB4 immunofluorescence shows no change in vascular density in Jag1(ECKO)mice, as compared
to littermate controls.
(B) Quantification of vascular parameters at P6 in Jag1fl/fl controls and Jag1(ECKO) retinas. n = 3 per group/two independent experiments.
(C) Visualization of the BM vascular niche (VE-cadherin-Alexa Fluor 647/DAPI nuclear counterstain).
(D) Quantification of the BM vascular niche shows no significant difference between the numbers of functionally patent CD45Ter119VEcadherin+Isolectin
GS-IB4+ BM endothelial cells. n = 5 for each experimental group for three independent experiments.
(E) Bone marrow endothelial cells were isolated and subjected to angiocrine profiling for known prohematopoietic angiocrine factors. The angiocrine profile was
not significantly different between the Jag1fl/fl and Jag1(ECKO) cohorts except for Vcam1. n = 3 for each experiment group.
(F) Due to the role of Vcam in homing of HSPCs, we performed a 16 hr homing assay where 105 whole BM from CD45.1 mice was transplanted into lethally
irradiated Jag1fl/fl controls and Jag1(ECKO) mice and analyzed for donor engraftment 16 hr posttransplant. Note that there were no significant differences in the
homing of wild-type whole BM into control and Jag1(ECKO) recipients.
NS, nonsignificant; scale bar 50 mm. See also Table S1 and Figure S2. All data represent mean ± SD (*p<0.05).and performed quantitative RT-PCR for known prohemato-
poietic angiocrine factors (Figure 5E; Table S1). We found that
the majority of the angiocrine factors screened, including Kit-
Ligand (Ding et al., 2012) and Sdf-1 (Ding and Morrison, 2013),
did not result in significant changes when Jagged-1 was deleted
from endothelial cells. However, we did find a small, but signifi-
cant, increase in Vcam-1 and an upward trend in E-selectin
expression in endothelial cells lacking Jagged-1 (Figure 5E,
panel 1). The increase in adhesion molecules led us to hypothe-
size that there could be a defect in the homing of transplanted
HSPCs (Lapidot et al., 2005; Papayannopoulou and Craddock,
1997). To address these concerns, we performed a 16 hr homing
assay. We found that there were no significant differences in the
homing of HSPCs when assayed in the Jag1(ECKO) background
(Figure 5F). These data further support our conclusion that endo-
thelial-specific Jagged-1 directly regulates the maintenance and
self-renewal of the HSC pool.
To address whether Notch signaling was directly affected
by deletion of Jagged-1 in endothelial cells, we isolated BM
endothelial cells from Jag1fl/fl control and Jag1(ECKO) mice and
analyzed theexpression levels ofNotch receptors,Notch ligands,
and downstreamNotch targets. We found that there were similar
levels of Notch receptors and ligands, with the exception of Jag-
ged-1.However, our analysis revealed that therewasasignificant
decrease in Notch downstream targets suggesting that Notch
signaling is altered in Jag1(ECKO)BM endothelial cells (Figure S2).
Although the decrease in endothelial Notch signaling suggests a
potential indirect effect that could lead to the hematopoietic1028 Cell Reports 4, 1022–1034, September 12, 2013 ª2013 The Audefects seen in Jag1(ECKO)mice, our postnatal retinal angiogenic
assay suggest that the partial inhibition of Notch signaling in BM
endothelial cells does not perturb postnatal vascular integrity that
might alter the instructive function of the BM vascular niche in
supporting the reconstitution of the hematopoietic system.These
data, along with the finding that the angiocrine profiles of Jag1fl/fl
control and Jag1(ECKO) mice are similar (Figure 5), suggest that
endothelial-specific deletion of Jagged-1 negatively regulates
hematopoietic function in a Notch-dependent manner due to
the loss of their instructive capacity to support the maintenance
and regeneration of the hematopoietic system.
Endothelial-Specific Jagged-1 Does Not Alter
the Function of Nonendothelial BM Niche Cells
Although Notch signaling in HSPCs is inhibited following deletion
of EC-specific Jagged-1, it is still plausible that the hematopoietic
defects demonstrated in Jag1(ECKO)mice could be due to altered
numbers of other BM niche cells or inhibition of proper mesen-
chymal stem cell (MSC) function (Hilton et al., 2008). To address
this issue, we analyzed if nonendothelial BM niche cells were
affected by the endothelial-specific deletion of Jagged-1. We
found that the total number of nonvascular niche cells, including
CD45Ter119CD31 stromal cells, Osteopotin+ osteoblasts
(Nilsson et al., 2005), and PDGFRa+ CD51+ MSCs (Frenette
et al., 2013; Pinho et al., 2013) or Leptin Receptor+ (Ding et al.,
2012) perivascular niche cells, was similar between Jag1fl/fl con-
trol and Jag1(ECKO) mice (Figures 6A–6D). Furthermore, we have
isolated CD45Ter119CD31 stromal cells from Jag1fl/fl controlthors
Figure 6. Jag1(ECKO) Mice Do Not Manifest Alterations to the Mesenchymal Stem Cell or Perivascular Niches in the BM Microenvironment
(A) Quantification of nonvascular stromal cells.
(B–D) Within the nonvascular niche cell compartment, we quantified (B) osteopontin+ osteoblast niche cells and (C) Leptin Receptor+ and (D) PDGFRa+/CD51+
perivascular niche cells. Note that endothelial-specific deletion of Jagged-1 does not result in dropout of other critical BM niche cells. n = 9 per cohort/three
independent experiments.
(E and F) MSC activity of CD45 Ter119 CD31 stromal cells in Jag1fl/fl and Jag1(ECKO)mice. No differences were detected in the (E) number of CFU-Fs and (F)
clonal mesenspheres derived from 10,000 sorted CD45 Ter119 CD31 bone marrow stromal cells isolated from Jag1fl/fl and Jag1(ECKO) mice. Each
functional assay was independently repeated three times with n = 3 mice per test. These data suggest that the hematopoietic defect observed in Jag1(ECKO)
mice is not an indirect result of alterations to the architectural integrity and geometry of the BM niche, rather a direct instructional role of endothelial
cell-specific Jagged-1 expression. n = 9 for each experimental group for three independent experiments. All data represent mean ± SD. ns, statistically
nonsignificant.and Jag1(ECKO)mice andassessed their ability to perform in func-
tional mesenchymal stem/progenitor assays (Figures 6E and 6F).
We performed colony-forming unit fibroblast (CFU-F) assays
and clonal mesensphere assays to quantify functional MSCs
(Me´ndez-Ferrer et al., 2010). We found that there were no signif-
icant differences in the mesenchymal stem/progenitor functional
capacity of stromal CD45Ter119CD31 BM cells between
Jag1fl/fl control and Jag1(ECKO) mice (Figures 6E and 6F). There-
fore, these data suggest that Jagged-1 deletion in endothelial
cells does not alter the function of nonvascular components of
the BM microenvironment.
Endothelial cell Jagged-1 Regulates Quiescence and
Self-Renewal of HSCs
Studies have demonstrated that Jagged-1 produced by osteo-
blasts can maintain HSCs in a quiescent state (Calvi et al.,
2003). Accordingly, endothelial Jagged-1 could potentially con-
trol the quiescence state of a subpopulation of the HSC poolCell Reduring hematopoietic regeneration, ensuring the sustainability
of functional hematopoiesis. This notion suggests that the
hematopoietic defect seen in Jag1(ECKO) mice could be due to
the premature exhaustion of the HSC pool. To test this hypothe-
sis, we analyzed the cell-cycle status of Jag1fl/fl control and
Jag1(ECKO) mice. We examined the percentage of whole
BM, Lineage hematopoietic progenitors, KLS HSPCs, and
KLS.SLAM LT-HSCs that were in G0 by Ki67 and Hoechst
33342cell-cycle staining (Figure7A). Thepercentageofquiescent
hematopoietic cells inwhole BMshowedno significant difference
between the two cohorts. Upon further analysis of hematopoietic
subpopulations enriched for stem cell activity, we found that the
Jag1fl/fl control cohort maintained a significant population of
HSCs in G0 as compared to Jag1
(ECKO)mice in the lineage-nega-
tive subpopulation (Figure 7A).Analysis of theenrichedHSPCand
LT-HSC populations demonstrated that Jag1(ECKO) mice had a
marked decrease in the percentage of quiescent hematopoietic
cells as compared to Jag1fl/fl controls (Figure 7A).ports 4, 1022–1034, September 12, 2013 ª2013 The Authors 1029
Figure 7. Endothelial-Specific Deletion of Jagged-1 Impairs the Self-Renewal Potential of HSCs
(A) Steady-state cell-cycle analysis of hematopoietic subpopulations from Jag1fl/fl control and Jag1(ECKO)mice basedonKi67/Hoechst 33342 intracellular staining.
Whole BM from both cohorts showed no significant difference in their cell-cycle status. However, there was a significant decrease in the percentage of cells that
were in G0/quiescence in Jag1
(ECKO)mice in the hematopoietic subpopulations (Lineage Negative, KLS HSPCs, and KLS.SLAM) as compared to Jag1fl/fl controls.
(B) Survival curve monitoring the morbidity/mortality of Jag1fl/fl and Jag1(ECKO) mice following weekly injections of a sublethal dose of 5-FU (150 mg/kg).
Jag1(ECKO)mice succumbed to hematopoietic failure by 14weeks after serial 5-FU injections, whereas Jag1fl/fl control mice had a significant increase in longevity,
with the entire cohort dying at 19 weeks after serial 5-FU injections.
(C) Schematic depicting transplantation strategy.
(D) Jag1fl/fl Control and Jag1(ECKO) mice were lethally irradiated (950 Rads) and were transplanted with 5 3 105 whole BM from CD45.2 wild-type mice. Four
months posttransplant, primary CD45.2 cells were competitively transplanted with CD45.1 whole BM into secondary and tertiary Jag1fl/fl and Jag1(ECKO) re-
cipients. CD45.2 engraftment 4months after secondary transplant demonstrates that endothelial-specific deletion of Jagged-1 results in a significant decrease in
engraftment efficiency and self-renewal potential.
All data represent mean ± SD (*p < 0.05, ***p < 0.001).The increased cycling of HSPCs and LT-HSCs in Jag1(ECKO)
mice suggest that under regenerative stress, that lack of endo-
thelial Jagged-1 may lead to the premature exhaustion of
HSCs. To address this question, Jag1fl/fl control and Jag1(ECKO)
mice were treated weekly by administration of the myelosup-
pressive agent 5-fluorouracil (5-FU; 100 mg/kg) to induce
cycling of HSCs and to serially deplete the regenerative capac-
ity of the hematopoietic progenitors (Figure 7B). The rate of he-
matopoietic recovery and percentage of survival of each cohort
were monitored. Control groups succumbed to hematopoietic
failure at the ninth week, with the entire cohort failing to survive
by the 19th week (Figure 7B). Endothelial-specific deletion of
Jagged-1 significantly reduced the survival rate, with the major-
ity of the deaths detected between the 5th and 14th week
(Figure 7B).1030 Cell Reports 4, 1022–1034, September 12, 2013 ª2013 The AuTo test if endothelial Jagged-1 exerts its biological effect on
regulating HSC self-renewal, we transplanted 5 3 105 wild-
type CD45.2 whole BM into primary Jag1fl/fl control and Ja-
g1(ECKO) recipients and allowed 4months for recovery and stabi-
lization of the hematopoietic system (Figures 7C and 7D).We iso-
lated whole BM from the primary transplant recipients and
performed a competitive repopulation assay by transplanting 5
3 105 CD45.2whole BMwith 53 105 CD45.1whole BM into sec-
ondary and then tertiary Jag1fl/fl control and Jag1(ECKO) recipi-
ents (Figures 7C and 7D). By preconditioning wild-type CD45.2
hematopoietic cells in Jag1(ECKO) mice and competitively trans-
planting the CD45.2 hematopoietic cells back into Jag1(ECKO)
mice, we demonstrated that endothelial-specific deletion of Jag-
ged-1 has a negative impact on stem cell engraftment and he-
matopoietic regeneration. Therefore, endothelial cell-specificthors
expression of the Jagged-1 balances the quiescence and self-
renewal of HSCs.
DISCUSSION
Our data demonstrate that endothelial-specific deletion of Jag-
ged-1 results in a decrease in functional hematopoiesis by inter-
fering with Notch signaling in the HSPC pool. Cell-cycle and
functional transplantation analysis revealed that HSCs from
Jag1(ECKO) mice have decreased self-renewal potential, and a
greater proportion were driven from a quiescent state. Endothe-
lial-specific deletion of Jagged-1 leads to the premature exhaus-
tion of the HSC pool due to the inability of Jagged-1-deficient
endothelial cells to maintain the self-renewal ability of the HSC.
These data suggest that during steady-state hematopoiesis,
angiocrine expression of Jagged-1 by the endothelial cells regu-
late the quiescence and maintenance of the HSC pool as well
as lineage-specific differentiation of progenitors. Upon myelo-
suppressive insult, endothelial-specific Jagged-1 maintains the
HSC pool by balancing the rate of self-renewal and lineage-
specific differentiation of hematopoietic progenitors, ensuring
hematopoietic recovery to homeostatic levels. Therefore, endo-
thelial cells play an instructive role in orchestrating the quies-
cence, self-renewal, and reconstitution of the hematopoietic
compartment.
In this study, we deleted Jagged-1 in endothelial cells by uti-
lizing a constitutive VE-cadherin cre system. One major advan-
tage to utilizing VE-cadherin cre is that it is constitutively
expressed during both physiological and pathological condi-
tions in adult endothelial cells (Lambeng et al., 2005). Addition-
ally, as the majority of the endothelial cells in the adult are
quiescent during homeostatic conditions, the constitutive VE-
cadherin cre transgenic mouse line provides a completely
penetrant and a reproducible system to excise Jag1fl/fl alleles
(Figure 1), making it an ideal model to study the role of endo-
thelial-specific expression of Jagged-1 during steady-state
and regenerative hematopoiesis. Notably, in contrast to the
previously published endothelial-specific deletion of Jagged-1,
that employed the constitutive Tie2 cre mouse line (High
et al., 2008), the deletion of Jagged-1 by the constitutive
VE-cadherin cre mouse line does not result in embryonic
lethality, likely due to the delayed developmental expression
of VE-cadherin (Hofmann et al., 2012).
Notwithstanding the complexities of vascular-specific pro-
moters, this model poses two potential caveats. The first is
that it is plausible that the hematopoietic defects demonstrated
in Jag1(ECKO)mice was due to a decrease in the passive function
of endothelial cells to deliver the proper nutrients necessary to
promote efficient regeneration of the hematopoietic system. To
address this concern, we analyzed Jag1(ECKO) BM endothelial
cells for postnatal vascular and angiocrine defects and the effect
of endothelial-specific deletion of Jagged-1 on hematopoietic
niche cells within the BM microenvironment. We demonstrated
that endothelial-specific deletion of Jagged-1 did not disrupt
vascular and angiocrine integrity or affect numbers or function
of other BM hematopoietic niche cells (Figures 5 and 6). The sec-
ond caveat is that during embryonic development a subset of
embryonic hematopoietic cells express VE-cadherin. It hasCell Rebeen shown that the majority of the stem cell function can be
found in the CD45+VEcadherin+ hematopoietic population up
until day E16.5 of fetal liver hematopoiesis (Kim et al., 2005).
Therefore, it is possible that the hematopoietic defect we
observed in Jag1(ECKO) mice is due to intrinsic effects on the
HSC. To address this issue, we isolated E13.5 fetal liver hemato-
poietic cells from wild-type mice using CD45 and VE-cadherin
antibodies, demonstrating that the CD45+VE-cadherin and
CD45+VE-cadherin+ hematopoietic populations did not express
Jagged-1 protein (Figure S3). By contrast, the stromal popula-
tions phenotypically identified as CD45 VE-cadherin+ and
CD45VE-cadherin expressed significant levels of Jagged-1
protein, with the magnitude of Jagged-1 in the endothelial cell
population (CD45 VE-cadherin+) being significantly more pro-
nounced than the other cell populations (Figure S3). However,
it is plausible that endothelial-specific Jagged-1 plays an essen-
tial role during development in supporting the establishment and
maintenance of the hematopoietic system (Robert-Moreno et al.,
2008). Therefore, the hematopoietic defects displayed in adult
Jag1(ECKO) mice could reflect a developmental effect of endo-
thelial-specific Jagged-1. Nonetheless, the self-renewal data
presented in Figures 7C and 7D indicate that expression of
Jagged-1 in adult endothelial cells regulates hematopoiesis by
providing instructive cues that support the maintenance of the
adult HSC.
Our studies suggest that endothelial cell Jagged-1 plays an
essential role in adult hematopoiesis and that the Notch pathway
is critical in maintaining homeostatic and regenerative hemato-
poiesis. However, the role of Notch signaling in the regulation
of postnatal hematopoiesis is a debatable subject. In contrast
to our studies (Butler et al., 2010; Kobayashi et al., 2010), and
many others (Duncan et al., 2005; Karanu et al., 2000; Stier
et al., 2002; Varnum-Finney et al., 2011; Varnum-Finney et al.,
2000), the Notch pathway has been suggested to be dispens-
able for adult hematopoiesis (Maillard et al., 2008; Mancini
et al., 2005). One explanation for the discrepancy in Maillard
et al. with our present study is the compensatory roles of other
mastermind-like family members (Oyama et al., 2011) in which
mastermind-like 3 can compensate for mastermind-like1 in bio-
logical functions. Additionally, the deletion of RBPJ removes its
function as a natural repressor of canonical Notch signaling
(Hsieh et al., 1999; Kao et al., 1998; Lai, 2002; Nagel et al.,
2005). Hence, it is conceivable that one could still have basal
levels of canonical Notch signaling even in the absence of intra-
cellular Notch/RBPJ-mediated canonical Notch signaling. It has
also been suggested that the use of dominant-negative master-
mind-like1 mice and retrovirus still result in low levels of canon-
ical Notch signaling (Oyama et al., 2007; Wu et al., 2007).
Furthermore, the use of the Mx1 and Vav transgenic promoters
to drive Cre expression in the aforementioned studies could
have lead to the opposite results in the hematopoietic mouse
models employed in these studies. In summary, our data
demonstrate that endothelial-specific Jagged-1 is a critical pro-
hematopoietic angiocrine factor that fosters the maintenance of
the HSC pool. This finding further defines the vascular niche as a
crucial cellular hub among other niche cells that sustains the ho-
meostatic and regenerative capacity of the hematopoietic
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EXPERIMENTAL PROCEDURES
Mice
All animal experiments were performed under the approval of Weill Medical
College of Cornell University’s Institutional Animal Care and Use Committee.
C57BL/6J (CD45.2) and B6.SJL-Ptprca Pepcb/BoyJ (CD45.1) mice were
used at 8–10 weeks of age. VE-cadherin cre mice were obtained from Luisa
Iruela-Arispe at UCLA. VE-cadherin creERT2 mice were obtained from Ralf
H. Adams. B6.Cg-Tg(Mx1-cre)1Cgn/J mice were obtained from The Jackson
Laboratory. Jag1fl/fl mice were obtained from Jon Epstein at University of
Pennsylvania (High et al., 2008) and were generated by Kathleen Loomes
and Klaus Kaestner (Loomes et al., 2007). Hes1-GFP knockin mice were ob-
tained from Iannis Aifantis at New York University. All experimental mice
were maintained on the C57BL/6J (CD45.2) background.
Generation of Jag1fl/fl Control and Jag1(ECKO) Endothelial Cells
Lung endothelial cells were isolated from Jag1fl/fl and Jag1(ECKO)mice as pre-
viously described (Fehrenbach et al., 2009). Endothelial cells were grown in 1:1
DMEM:Ham’s F-12 supplemented with 20% FBS, 20 mM HEPES (Invitrogen),
100 mg/ml heparin (Sigma), 100 mg/ml endothelial cell mitogen (Biomedical
Technologies), MEM nonessential amino acids (Cellgro), and penicillin/strep-
tomycin (Cellgro) and infected with a myristoylated-Akt1 (myrAkt) lentivirus
as previously described (Kobayashi et al., 2010). myrAkt-expressing cells
were selected for 1 week in X-Vivo 20 media (Lonza) and returned to growth
media. Purity of endothelial cells was confirmed by flow cytometry and
confocal microscopy. For flow cytometry, cells were stained with antibodies
(clone) against CD31 (390) and VE-cadherin (BV13). All cells were blocked
with an antibody against CD16/32 (2.4G2) prior to antibody staining and
analyzed using a LSRII SORP (BD Biosciences). For microscopy, cells were
blocked with aCD16/32 and stained overnight at 4C with aVE-cadherin
(BV13). Following staining, cells were washed three times in PBS (pH 7.4) for
5 min each and incubated for 20 min at room temperature with DAPI nuclear
counterstain (Molecular Probes, 1:5,000). Samples were mounted using
VectaShield (Vector Laboratories) and were viewed with appropriate filters.
Antibodies were purchased from eBioscience or Biolegend.
Hematopoietic Coculture
Whole BM cells were isolated and enriched by Lineage Cell Depletion (Miltenyi
Biotech). Lineage-negative cells (105) were plated in one well of a 12-well plate
with Jag1fl/fl or Jag1(ECKO) endothelial cells; culture conditions consisted of
StemSpan serum-free media (Stem Cell Technologies) supplemented with
50 ng/ml of soluble Kit Ligand (sKitL) (Peprotech). Hematopoietic cells were
analyzed using antibodies (clones) recognizing the following surface markers:
c-Kit/CD117 (2B8), Sca-1/Ly-6A (D7), CD48 (HM48-1), and CD150
(mShad150). Lineage antibody cocktail included CD41 (MWReg30), CD3
(145-2C11), CD5 (53-7.3), CD4 (GK1.5), CD8 (53-6.7), Gr-1 (RB6-8C5),
CD11b (M1/70), Ter119 (Ter119), and B220 (6B2). All cells were blocked with
aCD16/32 (2.4G2) prior to antibody staining and analyzed using a LSRII
SORP (BD Biosciences). All antibodies were purchased from BD Pharmingen
or eBioscience.
Analysis of Steady-State Hematopoiesis
Syngenic Jag1fl/fl and Jag1(ECKO)micewere subjected to steady-state analysis
of progenitor activity and phenotypic analysis of differentiated cells and LT-
HSCs. Phenotypic analysis of hematopoietic cells was performed by isolating
whole BM from femurs by mechanically denuding all muscle and connective
tissue and were crushed in a sterile mortar and pestle and digested with
2.5 mg/ml Collagenase A (Roche) and 1 unit/ml Dispase II (Roche) in Hank’s
balanced salt solution at 37C for 30 min with gentle agitation. Resulting sus-
pensions were filtered through a 0.45 mm cell strainer (BD Falcon) to a single-
cell suspension. Antibodies used for lineage and LT-HSC analysis are also
described above. Hematopoietic cells were quantified by flow cytometry.
For cell-cycle analysis, hematopoietic cells were prepared using the Cytofix/
Cytoperm kit (BD Biosciences) and stained using Hoechst 33342 and a Ki67
antibody (B56, BD Biosciences). All cells were blocked with aCD16/32
(2.4G2) prior to antibody staining and analyzed using a LSRII SORP (BD
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CD45.1 recipients were irradiated (950 Rads) and transplanted with 5 3 105
CD45.2 hematopoietic cells in conjunction with a standard 5 3 105 CD45.1
whole BM competitive dose. Engraftment was monitored at 4, 8, 16, and
24 weeks by fluorescence-activated cell sorting (FACS) analysis of peripheral
blood for CD45.2/CD45.1 content (four independent experiments with n = 10
per cohort). For in vivo stem cell function, limiting dilution (Szilvassy et al.,
1990) and competitive repopulation assays (Harrison, 1980) were performed
in three independent experiments with n = 20 per cohort for limiting dilution
and n = 5 for competitive repopulation. The cell source was either CD45.2
whole BM or KLS hematopoietic cells, and cell dose was as indicated in the
figures and figure legends. Hematopoietic engraftment was monitored at 4,
8, 16, and 24 weeks by FACS analysis of peripheral blood for CD45.2/
CD45.1 content.
Hematopoietic Self-Renewal Assays
Jag1fl/fl control Jag1(ECKO)micewere subjected to serial intraperitoneal admin-
istration of the chemotherapeutic agent 5-fluorouracil (100 mg/kg). Mice were
monitored for signs of morbidity and sacrificed to ensure that mice did not
experience any undue discomfort.
Postnatal Retinal Analysis
Following sacrifice, eyes were enucleated and fixed in 4% paraformaldehyde
for 2 hr at 4C. Retinas were then dissected out and incubated in 0.5% Triton
X-100 and 1% BSA, overnight at 4C. Following washes in PBLEC (1% Triton
X-100, 1 mM MgCl2, 1 mM MnCl2, and 1 mM CaCl2 in PBS [pH 6.8]), retinas
were incubated overnight in PBLEC containing biotinylated Isolectin GS-B4
(Vector Labs, 1:50). Alexa Fluor streptavidin-conjugated secondary antibodies
were used (Invitrogen, 1:500) for detection. A Nikon A1R confocal microscope
was used to image the stained and flat-mounted retinas. Four 103 stacks
were taken of each retina. ImageJ was used for image processing and
quantification.
BM Niche Cell Quantification
For quantification of the BM endothelial cells, Osteopontin+ cells, and Nestin/
Leptin Receptor+ cells, mice were injected by retroorbital sinus with 10 mg of
Alexa Fluor 647-VE-cadherin (BV13) antibody. After 10 min, mice were sacri-
ficed, and femurs were denuded of muscle and connective tissue, crushed
in a sterile mortar, and digested as described above. Niche cells were quanti-
fied. The number of functional BMendothelial cells was quantified by analyzing
the total number of VE-cadherin+CD45–Ter119– cells per femur. Analysis of
expression of Osteopontin was determined by fixing CD45–Ter119–CD31
cells with 2%paraformaldehyde, permeabilized, and stained with Osteopontin
(AF497, R&D Systems). Analysis of PDGFRa+ CD51+ (BD Pharmingen) and
Leptin Receptor (IC808P, R&D Systems) was performed by cell-surface stain-
ing of CD45–Ter119–CD31 cells. All cells were blocked with aCD16/32
(2.4G2) prior to antibody staining and analyzed using a LSRII SORP (BD
Biosciences).
CFU-F and Clonal Mesensphere Formation Assays
BM cells were isolated as previously described (Me´ndez-Ferrer et al., 2010)
with minor modifications. Briefly, cells were gently flushed in L-15 FACS buffer
and after erythrocyte lysis, digested with 3 mg/ml Collagenase I (Sigma-
Aldrich) and 3 mg/ml Dispase (Gibco) in HBSS with 10% FBS (HyClone) for
30 min at 37C. Prior to flow cytometry sorting, cells were enriched by immu-
nomagnetic depletion using aCD45 magnetic beads (Milteyi Biotec), following
the manufacturer’s recommendations. CD45Ter119CD31 stromal cells
were sorted using fluorochrome-conjugated monoclonal antibodies specific
to mouse CD45 (30-F11), Ter119 (Ter-119) from eBioscience and CD31
(MEC13.3) from Biolegend, on a FACSAria (BD Biosciences) to > 95% purity.
For clonal sphere formation, cells were plated at clonal density (<1,000
cells/cm2) into ultralow adherent plates as previously described (Me´ndez-Fer-
rer et al., 2010). Cells were kept at 37Cwith 5%CO2 in a water-jacketed incu-
bator and left untouched for 1 week to prevent cell aggregation. One-half
medium changes were performed weekly, and spheres were counted at
day 9. For CFU-F assays, 10,000 sorted cells were seeded per well in 6-well
adherent tissue culture plate using phenol-red free a-MEM (Gibco)thors
supplemented with 20% FBS (HyClone), 10% MesenCult stimulatory supple-
ment (STEMCELL Technologies), and 0.5% penicillin-streptomycin. One-half
of the media was replaced after 7 days and at day 14 cells were stained with
Giemsa staining solution (EMD Millipore), and colonies were counted.
Immunostaining of Bone Sections
Mice were injected by retroorbital sinus with 10 mg of Alexa Fluor 647-VE-cad-
herin (BV13). After 10 min, bones from control and Jag1(ECKO) mice were fixed
overnight in 4C with 4% paraformaldehyde and were decalcified for 4 days in
10% EDTA (pH 7.2) at room temperature. Femurs were washed with PBS
(pH 7.4) for 30 min, placed in 30% sucrose at 4C overnight, and embedded
in Tissue-Tek Optimal Cutting Temperature (OCT). Sections were postfixed
for 15 min with 4% paraformaldehyde and washed three times with PBS. Sec-
tions were stained for 20 min at room temperature with DAPI nuclear counter-
stain (Molecular Probes, 1:5,000). Samples were mounted using VectaShield
(Vector Labs).
Peripheral-Blood Analysis
Retroorbital blood was collected on indicated days after sublethal irradiation
with capillary pipettes andwasanalyzed using anautomatedAdvia 120 (Bayer).
Cre Recombinase Efficiency
To isolate primary BM endothelial cells, mice were injected via retroorbital
sinus with 25 mg of Alexa-Fluor-647-conjugated VE-cadherin antibody
(BV13) and 50 mg Alexa-Fluor-488-conjugated Isolectin GS-B4 (Invitrogen).
After 10 min, total extracted BM endothelial cells were isolated as described
above. Live cells (DAPI) were gated on Isolectin GS-IB4+/VE-cadherin+ and
sorted directly into Trizol (Invitrogen) and total RNA was isolated following
the manufacturer’s protocol. All flow sorting was performed on an Aria II
SORP (BD Biosciences). Generation of complementary DNA (cDNA) from total
BM endothelial cell for RT-PCR analysis was achieved by using the Ovation
Pico WTA System V2 (NuGEN) according to the manufacturer’s protocol.
Semiquantitative RT-PCR was performed with 100 ng input cDNA using the
PCR Extender System (5 PRIME) at 94C 2 min - 94C 30 s, 58C 30 s, 72C
30 s (303) - 72C 5 min (see Table S1 for primer sequences). Products were
resolved on 2% agarose/TAE gels and visualized using ethidium bromide
and the Bio-Rad Universal Hood Imaging System.
Angiocrine Profiling of In Vivo BM Endothelial Cells
To generate cDNA for quantitative RT-PCR analysis, total extracted BM endo-
thelial cells were isolated (as described above), and total RNA was converted
to cDNA using qScript cDNA Supermix (Quanta) according to the manufac-
turer’s protocol. Quantitative RT-PCR was carried out using SYBR Green
PCR Master Mix (Applied Biosystems) with appropriate primers (see Table
S1 for primers sequences) on a ViiaA7 Real-Time PCR System (Applied Bio-
systems) according to the manufacturer’s protocol. Statistics were calculated
using Student’s t test on three biological replicates.
Statistics
Unless otherwise indicated, all data are represented as amean ± SD. Log rank
and two-tailed Student’s t tests and 95% confidence intervals were used to
determine statistical significance (*p < 0.05, **p < 0.01, ***p < 0.001).
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